Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).
about
The prion hypothesis in Parkinson's disease: Braak to the futureMultiple system atrophy: cellular and molecular pathology.Second consensus statement on the diagnosis of multiple system atrophyRiluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyp25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophyPropagation of prions causing synucleinopathies in cultured cellsReview: Multiple system atrophy: emerging targets for interventional therapiesGenetics Underlying Atypical Parkinsonism and Related Neurodegenerative DisordersEvidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonismPotential Interactions between the Autonomic Nervous System and Higher Level Functions in Neurological and Neuropsychiatric ConditionsMultiple system atrophy: a clinical and neuropathological perspectiveGlia and alpha-synuclein in neurodegeneration: A complex interactionExploring myelin dysfunction in multiple system atrophyAnimal modeling an oligodendrogliopathy--multiple system atrophySystems biology of neurodegenerative diseasesAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyMultiple system atrophy: clinicopathological characteristics in Japanese patients.The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease.Widespread alterations of alpha-synuclein in multiple system atrophyProgression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.Free-water imaging in Parkinson's disease and atypical parkinsonism.Confounders of vasovagal syncope: orthostatic hypotension.What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.The motor disorder of multiple system atrophy.Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairmentFilamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECTClinicopathological study of 35 cases of multiple system atrophy.Attentional functions in multiple system atrophy and Parkinson's diseaseMultiple system atrophy: a sporadic synucleinopathy.Towards translational therapies for multiple system atrophyNovel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literatureα-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophyMesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotectionDepression in multiple system atrophy: a case report.The pathogenesis of multiple system atrophy: past, present, and future.Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET dataEncephalomyelitis, brain tumors, neuromuscular diseases and miscellaneous disorders.
P2860
Q22001062-AAC91B33-DB57-4DBB-B2DE-D18C782E0ED3Q24535446-EB761313-4C7A-47FE-955D-51C43491A9BDQ24650965-847CD5E0-1991-4403-A1F3-8E6FC0612407Q24655620-8C4E1DEB-57FA-4C5C-8723-9761E742DD38Q24682056-B3687C95-5643-4191-86CF-A330871948E6Q26269822-9416DA55-C916-4883-B240-2F273D314CCFQ26770919-D668B639-2C24-4761-82DB-A66DF6277B13Q26779001-F54EB592-CEB3-4659-B8D3-F0A7AB0A7C35Q26782028-76851F3B-4393-4B58-95F4-921887FFB8A8Q26782934-652B1F09-6EF4-4D62-B9F4-8F4704A8F7DDQ26829838-9A9ED462-2DDE-4C0A-8EF2-18997AC397D7Q26851153-D919FF7E-B034-44F1-BC5D-171A544603EDQ26852634-E5C9CDB1-D002-443D-BD99-84C75B8CB944Q28074659-E94EC5C9-82E2-410C-BF47-336F744488C4Q28080741-7799E390-AEF9-479D-A799-576AF4891575Q28395248-FC7AF96E-81AC-4E95-89ED-F29BB9768357Q30234494-33698AC5-EE33-42A6-A23F-9F1F8A4DA005Q30443884-977D6047-7515-4C03-81D6-9ED6F515C988Q30444927-6C412975-6BAD-48FC-9EAB-16953FB7018AQ30688673-92A30498-1D70-40CF-8239-D931C68D13E4Q31034031-12E8B569-19B6-4DEE-BA54-4454E8CFE154Q33162128-7C33D394-F0E8-490D-BE3D-29457B53BA73Q33180015-D683F0F3-5253-4CED-A589-EF1181DD7D8BQ33470625-8E3B3950-336B-4051-A1BA-9BC12F49553DQ33592243-D3387C8B-D1A6-4A4E-B1E9-4F4A854029CEQ33601574-33335FE2-16E9-47EF-B60B-FD5758E182D1Q33703950-C2E205FE-4C22-45EB-B3B8-17E68FDD4ED4Q33733062-53D2F023-1E60-4560-846A-957A722399D4Q33733668-42643B6F-3EE0-4CEC-B7E8-BF35067794C4Q33735208-5B7E0624-D275-491C-9764-DE491BF11C79Q33750069-786993D9-3479-4FAD-8CCD-D1E653BA47A0Q33797532-BE6FC93B-FFE3-4E29-B27D-0458FB9293E9Q33805560-2DCA7C41-A6F0-4298-A755-DE03C3914F0AQ33838058-2D2BEA89-2359-4DB3-B6C8-A07872C9E4C9Q33864597-454E7562-7F76-4214-A411-C596CBD29E90Q33916838-666692BE-2A2C-4DBD-BE06-3B9C204D2B73Q34039898-63EED38A-E835-4639-87CF-FEAD57221B9AQ34048136-94B52D25-F94C-4D18-AF5B-EE96880A7EEBQ34060625-10C6F0D7-2773-46A3-B948-1D802E5972BAQ34063829-6AB2F6F2-D303-44C5-B2FE-D15876226E1E
P2860
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@ast
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@en
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@nl
type
label
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@ast
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@en
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@nl
prefLabel
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@ast
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@en
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@nl
P2093
P1476
Glial cytoplasmic inclusions i ...... ophy and Shy-Drager syndrome).
@en
P2093
P304
P356
10.1016/0022-510X(89)90219-0
P577
1989-12-01T00:00:00Z